Seamus Mulligan leads $20m funding at medtech Avectas
Drug delivery specialist aims to be key player as medicine turns to cell technology and personalised medicine to tackle cancers
Drug companies head off opioid trial with $260m settlement
Drugmaker Teva and three distributors reached a settlement with two US counties over their alleged role in the opioid addiction crisis, just moments before the start a trial
Seamus Mulligan leads $10m funding for cell therapy start-up
Avectas has now raised $20m as it looks to unlock potential of personalised medicine
Home-grown pharma and medtech strike near-billion-dollar deals
Cantillon: Indigenous firms Adapt, Chanelle and Novate show how to do business
What next for Séamus Mulligan?
Entrepreneur might turn attention to Maynooth University cancer therapy spinout
Making millions: how Irish team hit $735m jackpot with overdose rescue drug
US opioid crisis helped growth of overdose rescue drug marketed by Adapt Pharma
Six Irish men to share $635m after sale of drug firm
Adapt Pharma’s Narcan spray used in the front line of opioid crisis in United States
Overdose rescue drug Narcan earns Irish team $635m payout
Adapt Pharma sold to US group Emergent Biosolutions as US opioid crisis drives demand
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices